Citation Impact
Citing Papers
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
2010 Standout
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
2012 Standout
Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer
2012
Bone resorption predicts for skeletal complications in metastatic bone disease
2003
Validation of the pre-treatment neutrophil–lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients
2013
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2014 Standout
Differential Inhibition of Invasion and Proliferation by Bisphosphonates: Anti-Metastatic Potential of Zoledronic Acid in Prostate Cancer
2004
Cancer to bone: a fatal attraction
2011 Standout
A Double-Blind, Placebo-Controlled, Randomized Trial of Oral Sodium Clodronate for Metastatic Prostate Cancer (MRC PR05 Trial)
2003
Immune Contexture, Immunoscore, and Malignant Cell Molecular Subgroups for Prognostic and Theranostic Classifications of Cancers
2016
Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis
2008
Potential Use of Bisphosphonates in the Prevention of Metastases in Early-Stage Breast Cancer
2007
Synergistic cytotoxic effects of zoledronic acid and radiation in human prostate cancer and myeloma cell lines
2005
Zoledronate Sensitizes Endothelial Cells to Tumor Necrosis Factor-induced Programmed Cell Death
2003
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
2014 Standout
The immune contexture in cancer prognosis and treatment
2017 Standout
Effect of bisphosphonates on pain and quality of life in patients with bone metastases
2009
Induction of Cytoprotective Pathways Is Central to the Extension of Lifespan Conferred by Multiple Longevity Pathways
2012 StandoutNobel
Impact of skeletal complications on patients’ quality of life, mobility, and functional independence
2008
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
2004 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel
2007
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
2020 Standout
C-reactive protein as a biomarker for urological cancers
2011
Bisphosphonates in cancer therapy
2007
A Review of Integrated Staging Systems for Renal Cell Carcinoma
2012
Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
2020 StandoutNobel
Disease modifying and anti-nociceptive effects of the bisphosphonate, zoledronic acid in a model of bone cancer pain
2002
The biopsychosocial approach to chronic pain: Scientific advances and future directions.
2007 Standout
Mechanisms of Bone Metastasis
2004 Standout
Selective Blockade of the Capsaicin Receptor TRPV1 Attenuates Bone Cancer Pain
2005 StandoutNobel
Cancer-related inflammation and treatment effectiveness
2014 Standout
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
2006 Standout
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
2016 Standout
Renal cell carcinoma
2017 Standout
Studies Comparing Numerical Rating Scales, Verbal Rating Scales, and Visual Analogue Scales for Assessment of Pain Intensity in Adults: A Systematic Literature Review
2011 Standout
Mevalonate pathway: A review of clinical and therapeutical implications
2007
Osteonecrosis of the jaw complicating bisphosphonate treatment for bone disease in multiple myeloma: an overview with recommendations for prevention and treatment
2008
The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer
2012 Standout
Cancer Pain Assessment in Clinical Trials. A Review of the Literature (1999–2002)
2005
Bisphosphonates for advanced prostate cancer
2006
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Metastatic bone disease: clinical features, pathophysiology and treatment strategies
2001 Standout
Optimizing Clinical Benefits of Bisphosphonates in Cancer Patients with Bone Metastases
2010
Bone Turnover Mediates Preferential Localization of Prostate Cancer in the Skeleton
2005
Skeletal Complications of Breast Cancer Therapies
2006
Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity
2006 Standout
Multiple Myeloma
2011 Standout
Bisphosphonates for advanced prostate cancer
2017
American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update
2014 Standout
Works of S. Jagdev being referenced
Improving the accuracy of pre-operative survival prediction in renal cell carcinoma with C-reactive protein
2010
The anti-tumor potential of zoledronic acid
2003
The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel
2001
Comparison of the effects of intravenous pamidronate and oral clodronate on symptoms and bone resorption in patients with metastatic bone disease
2001